Hacker News new | comments | ask | show | jobs | submit login

Not a scam. Inflammatory banks are evil stuff with little to no support.

In hindsight it's easy to say they should have known it would get to this price but in the weeks leading up to the IPO it would have been pretty difficult to justify pricing at 80. The current price is difficult to justify and may not hold beyond this initial frothy period.

Add to that the greater downside of underpricing and I just don't think the author is really making much sense.




Applications are open for YC Summer 2019

Guidelines | FAQ | Support | API | Security | Lists | Bookmarklet | Legal | Apply to YC | Contact

Search: